Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILORIX: Tailored Infliximab Treatment in Crohn's Disease
NCT01442025Phase 4Completed
- Sponsor
- GETAID
- Start
- Jun 2012
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by GETAID. Started Jun 2012; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01442025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442025.